CA1337731C - Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule - Google Patents

Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule

Info

Publication number
CA1337731C
CA1337731C CA000556648A CA556648A CA1337731C CA 1337731 C CA1337731 C CA 1337731C CA 000556648 A CA000556648 A CA 000556648A CA 556648 A CA556648 A CA 556648A CA 1337731 C CA1337731 C CA 1337731C
Authority
CA
Canada
Prior art keywords
tetrapeptide
subjecting
reverse phase
silica
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000556648A
Other languages
English (en)
Inventor
Maryse Lenfant
Martine Guigon
Johanna Bakala
Emilia Frindel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Gustave Roussy (IGR)
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8610486A external-priority patent/FR2601678B1/fr
Application filed by Institut Gustave Roussy (IGR), Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Gustave Roussy (IGR)
Priority to CA000556648A priority Critical patent/CA1337731C/fr
Priority claimed from NO930799A external-priority patent/NO175102C/no
Application granted granted Critical
Publication of CA1337731C publication Critical patent/CA1337731C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000556648A 1986-07-18 1988-01-15 Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule Expired - Fee Related CA1337731C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000556648A CA1337731C (fr) 1986-07-18 1988-01-15 Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR8610486A FR2601678B1 (fr) 1986-07-18 1986-07-18 Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
AU10261/88A AU598897B2 (en) 1986-07-18 1988-01-14 Inhibitory tetrapeptide of entry into cycle of hemopoietic stem cells, processes for its preparation, and its uses
CA000556648A CA1337731C (fr) 1986-07-18 1988-01-15 Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule
NO880186A NO173655C (no) 1986-07-18 1988-01-18 Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale
NO930799A NO175102C (no) 1986-07-18 1993-03-04 Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH

Publications (1)

Publication Number Publication Date
CA1337731C true CA1337731C (fr) 1995-12-12

Family

ID=27506551

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000556648A Expired - Fee Related CA1337731C (fr) 1986-07-18 1988-01-15 Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule

Country Status (1)

Country Link
CA (1) CA1337731C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130137637A1 (en) * 2010-03-26 2013-05-30 Samsungn Life Welfare Foundation Peptides for promoting angiogenesis and an use thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130137637A1 (en) * 2010-03-26 2013-05-30 Samsungn Life Welfare Foundation Peptides for promoting angiogenesis and an use thereof
US9610318B2 (en) * 2010-03-26 2017-04-04 Industry-Academic Cooperation Foundation, Sookmyung Women's University Peptides for promoting angiogenesis and use thereof
US9938320B2 (en) 2010-03-26 2018-04-10 Industry-Academic Cooperation Foundation, Sookmyung Women's University Peptides for promoting angiogenesis and use thereof

Similar Documents

Publication Publication Date Title
US4571336A (en) Immune stimulation
US6239104B1 (en) Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
US4910296A (en) Medicaments containing alpha 1 thymosin fragments and having an immunostimulant action, and fragments of alpha 1 thymosin
CN100427502C (zh) 抗肿瘤寡肽及其制备方法和应用
US4612365A (en) Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
JPS60233098A (ja) 抗凝固作用を有する新規ポリペプチド
CN104918951B (zh) 多粘菌素、组合物、制备方法和使用方法
JPS6222799A (ja) 血液凝固阻害作用を有する新規ポリペプチド
US4470926A (en) Medicaments containing thymosin alpha 1 fragments and having an immunostimulant action, and fragments of thymosin alpha 1
US5114926A (en) Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses
Reimer et al. Small-scale solid-phase O-glycopeptide synthesis of linear and cyclized hexapeptides from blood-clotting factor IX containing O-(α-D-Xyl-1→ 3-α-D-Xyl-1→ 3-β-D-Glc)-L-ser
CZ287816B6 (en) Peptide, process of its preparation, pharmaceutical preparation in which it is comprised and use thereof
Abiko et al. Identification and synthesis of a heptapeptide in uremic fluid
EP0288965A2 (fr) Peptides inhibant l'activité de phospholipase-A2
CA1176193A (fr) Peptide, procede de preparation et compose pharmaceutique le contenant
US4384991A (en) Process for the preparation of a biologically active substance for selective inhibition of the proliferation of leukemic and normal myeloid cells
RU2141337C1 (ru) Соединения на основе реакции амадори, их применение, способ получения и составы на их основе
EP0310887B1 (fr) Peptide vaso-constricteur
CA1337731C (fr) Tetrapeptide protegeant les cellules souches hematopoietiques, procedes de fabrication et utilisation de cette molecule
CN112851755B (zh) 一种线性脂肽化合物及其制备方法与应用
DK171969B1 (da) Tetrapeptid, dets fremstilling og anvendelse
CN111603567A (zh) Cd44靶向多臂偶联物
US6015878A (en) Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application
DE3781691T2 (de) Tetrapeptid-hemmstoff zum eintritt in den kreislauf von hemopoietischen stammzellen, verfahren zu deren herstellung und deren anwendungen.
NO175102B (no) Analogifremgangsmåte for syntese av tetrapeptidet Ser-Asp-Lys-Pro-OH

Legal Events

Date Code Title Description
MKLA Lapsed